Krystal Biotech
KRYS
KRYS
280 hedge funds and large institutions have $4.94B invested in Krystal Biotech in 2025 Q3 according to their latest regulatory filings, with 47 funds opening new positions, 104 increasing their positions, 85 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
1.06% more ownership
Funds ownership: 95.71% → 96.77% (+1.1%)
0% more funds holding in top 10
Funds holding in top 10: 7 → 7 (0)
63% less call options, than puts
Call options by funds: $43.1M | Put options by funds: $116M
Holders
280
Holding in Top 10
7
Calls
$43.1M
Puts
$116M
Top Buyers
| 1 | +$106M | |
| 2 | +$36.3M | |
| 3 | +$24M | |
| 4 |
ACA
Avoro Capital Advisors
New York
|
+$20.8M |
| 5 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$16.9M |
Top Sellers
| 1 | -$36.6M | |
| 2 | -$32.1M | |
| 3 | -$23.5M | |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
-$13.7M |
| 5 |
RAM
Readystate Asset Management
Chicago,
Illinois
|
-$13.7M |
